Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Gross Profit: 2021-2025

Historic Gross Profit for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Sep 2025 value amounting to $160.6 million.

  • Kiniksa Pharmaceuticals International's Gross Profit rose 74.36% to $160.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $523.3 million, marking a year-over-year increase of 57.87%. This contributed to the annual value of $362.3 million for FY2024, which is 52.98% up from last year.
  • Kiniksa Pharmaceuticals International's Gross Profit amounted to $160.6 million in Q3 2025, which was up 16.21% from $138.2 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Gross Profit registered a high of $160.6 million during Q3 2025, and its lowest value of -$155.0 million during Q4 2022.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Gross Profit had a median value of $92.1 million in 2024 and averaged $93.1 million.
  • The largest annual percentage gain for Kiniksa Pharmaceuticals International's Gross Profit in the last 5 years was 888.40% (2022), contrasted with its biggest fall of 1,141.85% (2022).
  • Kiniksa Pharmaceuticals International's Gross Profit (Quarterly) stood at $14.9 million in 2021, then crashed by 1,141.85% to -$155.0 million in 2022, then spiked by 147.62% to $73.8 million in 2023, then surged by 41.77% to $104.6 million in 2024, then spiked by 74.36% to $160.6 million in 2025.
  • Its Gross Profit was $160.6 million in Q3 2025, compared to $138.2 million in Q2 2025 and $119.9 million in Q1 2025.